ESPR vs. SSRM
ESPR (Esperion Therapeutics, Inc.) and SSRM (SSR Mining Inc.) are both stocks. ESPR operates in Biotechnology (Healthcare), while SSRM operates in Gold (Basic Materials). Over the past 10 years, ESPR returned -14.95%/yr vs 9.58%/yr for SSRM. At a 0.08 correlation, their price movements are largely independent.
Performance
ESPR vs. SSRM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESPR achieves a -14.86% return, which is significantly lower than SSRM's 24.22% return. Over the past 10 years, ESPR has underperformed SSRM with an annualized return of -14.95%, while SSRM has yielded a comparatively higher 9.58% annualized return.
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
SSRM
- 1D
- 3.46%
- 1M
- -21.64%
- YTD
- 24.22%
- 6M
- 22.60%
- 1Y
- 119.07%
- 3Y*
- 25.15%
- 5Y*
- 9.84%
- 10Y*
- 9.58%
ESPR vs. SSRM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 29.63% | -30.13% | 425.88% |
SSRM SSR Mining Inc. | 24.22% | 214.94% | -35.32% | -29.94% | -10.02% | -10.90% | 4.41% | 59.31% | 37.54% | -1.46% |
Correlation
The correlation between ESPR and SSRM is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2013 | 0.08 |
Fundamentals
ESPR:
$791.76M
SSRM:
$5.93B
ESPR:
-$0.03
SSRM:
$3.27
ESPR:
1.75
SSRM:
3.11
ESPR:
$418.24M
SSRM:
$1.90B
ESPR:
$226.32M
SSRM:
$643.76M
ESPR:
$77.18M
SSRM:
$835.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESPR vs. SSRM — Risk / Return Rank
ESPR
SSRM
ESPR vs. SSRM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and SSR Mining Inc. (SSRM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESPR | SSRM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.30 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 3.07 | 3.83 | -0.75 |
| Martin ratioReturn relative to average drawdown | 7.68 | 9.89 | -2.21 |
Loading charts...
Drawdowns
ESPR vs. SSRM - Drawdown Comparison
The maximum ESPR drawdown since its inception was -99.37%, which is greater than SSRM's maximum drawdown of -91.68%. Use the drawdown chart below to compare losses from any high point for ESPR and SSRM.
Loading charts...
Drawdown Indicators
| ESPR | SSRM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -91.68% | -7.69% |
Max Drawdown (1Y)Largest decline over 1 year | -53.19% | -31.28% | -21.91% |
Max Drawdown (3Y)Largest decline over 3 years | -80.94% | -73.41% | -7.53% |
Max Drawdown (5Y)Largest decline over 5 years | -97.16% | -83.16% | -14.00% |
Max Drawdown (10Y)Largest decline over 10 years | -99.10% | -83.16% | -15.94% |
Current DrawdownCurrent decline from peak | -97.27% | -37.45% | -59.82% |
Average DrawdownAverage peak-to-trough decline | -69.99% | -57.15% | -12.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.30% | 12.09% | +9.21% |
Volatility
ESPR vs. SSRM - Volatility Comparison
The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.06%, while SSR Mining Inc. (SSRM) has a volatility of 19.31%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than SSRM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESPR | SSRM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.06% | 19.31% | -18.25% |
Volatility (6M)Calculated over the trailing 6-month period | 61.44% | 54.27% | +7.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.66% | 66.63% | +26.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.79% | 55.93% | +35.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.61% | 52.96% | +31.65% |
Dividends
ESPR vs. SSRM - Dividend Comparison
Neither ESPR nor SSRM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SSRM SSR Mining Inc. | 0.00% | 0.00% | 0.00% | 2.60% | 1.79% | 1.13% |
Financials
ESPR vs. SSRM - Financials Comparison
This section allows you to compare key financial metrics between Esperion Therapeutics, Inc. and SSR Mining Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ESPR vs. SSRM - Profitability Comparison
ESPR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 80.10M. Therefore, the gross margin over that period was 0.0%.
SSRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported a gross profit of 0.00 and revenue of 581.78M. Therefore, the gross margin over that period was 0.0%.
ESPR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported an operating income of -6.58M and revenue of 80.10M, resulting in an operating margin of -8.2%.
SSRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported an operating income of 300.38M and revenue of 581.78M, resulting in an operating margin of 51.6%.
ESPR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a net income of -25.20M and revenue of 80.10M, resulting in a net margin of -31.5%.
SSRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, SSR Mining Inc. reported a net income of 369.74M and revenue of 581.78M, resulting in a net margin of 63.6%.
Frequently Asked Questions
ESPR and SSRM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SSRM has higher volatility (19.31%) compared to ESPR (1.06%). In terms of maximum drawdown, ESPR dropped -99.37% vs SSRM's -91.68%.
SSRM currently has the higher Sharpe Ratio (1.80 vs 1.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESPR and SSRM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer